CASEY REALZOLA: Open Payments
NPI 1568171767 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 7 payments from 7 companies in 2025. Trend: 2023 $234 · 2024 $173 · 2025 $760
Food & beverage: $760
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $169 |
| Janssen Biotech, Inc. | 1 | $140 |
| Novo Nordisk Inc | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Hologic Sales and Service, LLC | 1 | $119 |
| COLOPLAST CORP | 1 | $76 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $11 |
Products named: SAPIEN 3 Ultra RESILIA, TREMFYA, Wegovy, APTIMA, Titan, LifeVest.
Industry payments across MD — which companies pay providers there.
